Callos Andrew — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Callos Andrew has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $9.72M.

Profile

Andrew Callos is the Executive Vice President and Chief Commercial Officer at Cytokinetics Inc, a biopharmaceutical company focused on developing treatments for diseases affecting muscle performance. He has been involved in the company's commercial strategy and operations, contributing to its mission in the biopharmaceutical industry.

Board memberships

• Cytokinetics Inc

Awards & honors

• Leadership in commercial strategy at Cytokinetics
• Contributions to drug development for muscle-related diseases

Recent Transactions

Companies — Last 90 Days

• CYTOKINETICS INC (CYTK) — 4 filings, last 2026-07-02

Frequently Asked Questions

Who is Callos Andrew?

Andrew Callos is the Executive Vice President and Chief Commercial Officer at Cytokinetics Inc, a biopharmaceutical company focused on developing treatments for diseases affecting muscle performance. He has been involved in the company's commercial strategy and operations, contributing to its mission in the biopharmaceutical industry.…

How many SEC Form 4 filings has Callos Andrew submitted recently?

4 primary Form 4 filings in the last 90 days, covering 1 company.

Has Callos Andrew been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 21 open-market sales ($9.72M) across all tracked filings.

Where can I see all of Callos Andrew's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week